Guohong Li Selected Research

5- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dione

11/2020	Inhibition of PI3Kγ by AS605240 plus low-dose tissue plasminogen activator (tPA) combination improves thrombolytic therapy in a rat model of embolic stroke.
1/2019	PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guohong Li Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 01/2009
10	Stroke (Strokes) 06/2022 - 08/2010
10	Ischemic Stroke 01/2022 - 04/2008
7	Inflammation (Inflammations) 12/2019 - 08/2007
6	Infarction (Infarctions) 01/2022 - 07/2011
6	Neointima 01/2018 - 08/2002
5	Ischemia 10/2019 - 06/2010
5	Carcinogenesis 01/2017 - 01/2009
4	Cerebral Hemorrhage 01/2022 - 01/2018
4	Embolic Stroke 01/2022 - 01/2018
4	Thrombosis (Thrombus) 01/2019 - 09/2014
4	Vascular System Injuries 01/2014 - 12/2005
4	Leukemia 06/2012 - 01/2009
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2019
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 04/2013
3	Type 2 Diabetes Mellitus (MODY) 04/2020 - 09/2018
3	Atherosclerosis 02/2010 - 08/2002
2	Rupture 01/2022 - 04/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 12/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2020 - 04/2015
2	Brain Ischemia (Cerebral Ischemia) 10/2019 - 08/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 06/2010
2	Lung Neoplasms (Lung Cancer) 01/2017 - 04/2016
2	Infections 01/2016 - 04/2013
2	Hypoxia (Hypoxemia) 04/2013 - 07/2010
2	Vascular Diseases (Vascular Disease) 01/2013 - 09/2009
2	Genomic Instability 08/2011 - 10/2002
2	Hyperplasia 06/2010 - 01/2009
2	Atherosclerotic Plaque (Atheroma) 04/2008 - 12/2005
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	COVID-19 01/2022
1	Chromosome Duplication 12/2021
1	Cholera 10/2021
1	Embolism (Embolus) 11/2020
1	Rett Syndrome (Rett's Disorder) 01/2020
1	Neurodevelopmental Disorders 01/2020
1	Mastitis 12/2019
1	Neuroinflammatory Diseases 10/2019
1	Hepatocellular Carcinoma (Hepatoma) 07/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Diffuse Axonal Injury 01/2019

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 06/2010
5	MicroRNAs (MicroRNA)IBA 12/2017 - 09/2009
4	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2019 - 08/2010
4	P-SelectinIBA 01/2018 - 12/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2002
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2009
3	ChromatinIBA 01/2020 - 08/2015
3	EnzymesIBA 12/2019 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2010
3	Apolipoproteins E (ApoE)IBA 01/2018 - 12/2005
3	CD40 Ligand (CD40L)IBA 01/2018 - 04/2008
2	Messenger RNA (mRNA)IBA 01/2022 - 08/2010
2	Nucleosomes (Nucleosome)IBA 01/2022 - 12/2021
2	Histones (Histone)IBA 12/2021 - 06/2007
2	5- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dioneIBA 11/2020 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 07/2019 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2013
2	Neuroprotective AgentsIBA 01/2019 - 12/2017
2	FibrinIBA 01/2018 - 12/2017
2	ApolipoproteinsIBA 01/2018 - 12/2005
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2016 - 01/2015
2	Biological ProductsIBA 11/2016 - 01/2015
2	CarcinogensIBA 01/2015 - 01/2009
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2009 - 01/2009
1	mRNA VaccinesIBA 01/2022
1	J147IBA 01/2022
1	Histone ChaperonesIBA 12/2021
1	Cholera Vaccines FDA Link 10/2021
1	IodineIBA 01/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2020
1	Cholecalciferol (Vitamin D3)FDA Link 04/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 04/2020
1	Methyl-CpG-Binding Protein 2IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	LipopolysaccharidesIBA 12/2019
1	ImmunosorbentsIBA 12/2019
1	Interleukin-10 (Interleukin 10)IBA 12/2019
1	6-bromoindirubin-3'-oximeIBA 12/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2019
1	CytokinesIBA 10/2019
1	LipidsIBA 07/2019
1	Glucose (Dextrose)FDA LinkGeneric 07/2019
1	Sorafenib (BAY 43-9006)FDA Link 07/2019
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2019
1	Carcinoembryonic AntigenIBA 01/2019
1	AcidsIBA 01/2019
1	CarbohydratesIBA 01/2019

Therapy/Procedure

12	Therapeutics 01/2022 - 08/2007
4	Thrombolytic Therapy 01/2022 - 06/2010
4	Brachytherapy 01/2021 - 12/2015
2	Cognitive Training 06/2022 - 09/2017
2	Sutures (Suture) 01/2022 - 09/2014
2	Precision Medicine 01/2022 - 01/2018
2	Chemoradiotherapy 01/2021 - 12/2015
2	Chemoprevention 01/2015 - 01/2009
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021